Physician profile
James Longoria
NPI 1306845888
$36,333.66
in general payments reported to CMS, 2019-2025
19 companies · $666 in 2025
The $666 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,339 · 2020: $11K · 2021: $14K · 2022: $1,614 · 2023: $1,018 · 2024: $5,429 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,500 · Food and Beverage: $1,613.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,500.00 |
| Food and Beverage | $1,612.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $33,253.71 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Isolator Surgical Ablation System |
| Edwards Lifesciences Corporation | $624.65 | 2019-2025 | Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve |
| Abbott Laboratories | $614.10 | 2019-2024 | Epic |
| Medtronic Vascular, INC. | $486.22 | 2019-2020 | |
| Medtronic, INC. | $381.19 | 2021-2024 | Venaseal |
| Artivion, INC. | $167.50 | 2019 | |
| Livanova USA, INC. | $149.92 | 2019-2020 | |
| Getinge USA Sales, LLC | $123.15 | 2019-2025 | Vasoview Hemopro 2 |
| Covidien LP | $110.46 | 2019-2020 | |
| Abiomed | $89.78 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $65.24 | 2019-2020 | |
| Ethicon US, LLC | $61.14 | 2022 | |
| Stryker Corporation | $46.58 | 2025 | Revcore Thrombectomy Catheter |
| Terumo Cardiovascular Systems Corporation | $33.98 | 2019 | |
| Bolton Medical INC | $32.64 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiac Dimensions, INC. | $32.12 | 2024 | |
| Pfizer INC. | $25.62 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.00 | 2019 | |
| Boston Scientific Corporation | $17.66 | 2023 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Longoria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.